About Danopharm Private Limited
Data last updated: 17 December 2025
Danopharm Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Synergy Health Sciences Private Limited. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 15 January 2009, the company has been in operation for over 17 years.
Registered with ROC Mumbai under CIN U24100MH2009PTC189592.
Capital: an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. Formerly known as Danopharm Chemicals Limited and Danopharm Private Limited. It is led by directors including Jayanta Badalchandra Das and Kamlesh Badal Das.
Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: Unit No 117 Ravi Kiran 1St Floor Near Monginis Off New Link Road Andheri(West), Mumbai, Maharashtra, India – 400053.
As per the financials filed for FY 2025, the company reported a revenue of ₹108.78 Cr, a decline of 7% compared to the previous year.
The company has a workforce of approximately 85 employees as per the latest available data. It operates as a subsidiary of Synergy Health Sciences Private Limited.
The company is associated with 1 brand - Danopharm Chemicals. As per MCA filings, the company has open charges of ₹21.18 Cr and satisfied charges of ₹11.25 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website danopharm.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered AddressUnit No 117 Ravi Kiran 1St Floor Near Monginis Off New Link Road Andheri(West), Mumbai, Maharashtra, India – 400053
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Danopharm Private Limited
Danopharm Private Limited has undergone 2 name changes throughout its history. The company was previously known as Danopharm Chemicals Limited, and Danopharm Private Limited. The current legal name is Danopharm Private Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Danopharm Private Limited | Current |
| Danopharm Chemicals Limited | Previous |
Associated Brands with Danopharm Private Limited
Danopharm Private Limited operates one associated brand: Danopharm Chemicals. These brands represent Danopharm Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Manufactures high-quality bulk drugs and pharmaceutical intermediates. | danopharm.com |
Competitors & Alternatives of Danopharm Private Limited
Brands and companies operating in the same space as Danopharm Private Limited include Laurus Labs, Symbiotec, Beijing Biostar Technologies and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Laurus Labs
|
Pharmaceutical and biotechnology company | Hyderabad, India, India | 2005 |
Symbiotec
|
Non-sterile steroid hormone-based APIs and intermediates are manufactured. | Indore, India, India | 2002 |
Beijing Biostar Technologies
|
APIs, intermediates, and biochemical reagents are developed and manufactured. | Beijing, China, China | 2002 |
Sterling Pharma Solutions
|
Contract development, manufacturing, and analytical services for APIs are offered. | Dudley, United Kingdom, United Kingdom | 2016 |
Provepharm Life Solutions
|
APIs and drug products are developed and valorized in pharmaceuticals. | Marseille, France, France | 1998 |
Hikal
|
APIs and intermediates are produced via custom synthesis and research. | Mumbai, India, India | 1988 |
Snapdragon Chemistry
|
Drug discovery and development service provider | Cambridge, United States, United States | 2014 |
SeQuent
|
APIs are developed and manufactured for therapeutic areas. | Bengaluru, India, India | 2002 |
Jubilant Pharma
|
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | Noida, India, India | 1978 |
Business Activity of Danopharm Private Limited
Danopharm Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Danopharm Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Danopharm Private Limited
Danopharm Private Limited is audited by P N HATHI & Co. for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| P N HATHI & Co. | Locked | Locked | Locked |
Complete auditor history for Danopharm Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Danopharm Private Limited
Danopharm Private Limited is currently managed by 8 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Jayanta Badalchandra Das
Also directs:
Ankleshwar Waste Management Association
|
Director | 15 Jan 2009 | 17 Years 7 Months | Current |
| Kamlesh Badal Das | Director | 15 Jan 2009 | 17 Years 7 Months | Current |
| Satish Prabhakar Nachane | Director | 03 Sep 2009 | 17 Years 0 Months | Current |
|
Ramesh Eknath Jadhav
Also directs:
Synergy Health Sciences Private Limited
|
Director | 16 Mar 2010 | 16 Years 5 Months | Current |
|
Sabu Daniel
Also directs:
Synergy Health Sciences Private Limited
|
Director | 16 Mar 2010 | 16 Years 5 Months | Current |
| Kashinath Badal Das | Director | 15 Jan 2009 | 17 Years 7 Months | Current |
Financials of Danopharm Private Limited FY 2024 filings available
Danopharm Private Limited reported revenue of ₹108.78 Cr (down 7.00% YoY) for FY 2025.
Ten-year financial statements for Danopharm Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Danopharm Private Limited
Shareholding and ownership data for Danopharm Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Danopharm Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jul 2011 | State Bank of India | ₹21.18 Cr | Open |
| 15 Sep 2009 | United Bank of India | ₹11.25 Cr | Satisfied |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Danopharm Private Limited
Danopharm Private Limited has a workforce of 85 employees as of Apr 04, 2024.
Employee and EPFO history for Danopharm Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Danopharm Private Limited
GST registrations and filing compliance for Danopharm Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Danopharm Private Limited
Credit ratings, litigation, and regulatory alerts for Danopharm Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Danopharm Private Limited
MSME payment history for Danopharm Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Danopharm Private Limited
Corporate group structure for Danopharm Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Danopharm Private Limited
MCA filings and documents for Danopharm Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Danopharm Private Limited
Frequently Asked Questions about Danopharm Private Limited
Danopharm Private Limited is an active private limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 15 January 2009 (17+ years old) and is registered under CIN U24100MH2009PTC189592. The company has 85 employees.
Danopharm Private Limited reported revenue of ₹108.78 Cr for FY 2025 (down 7.00% YoY).
The current directors of Danopharm Private Limited are:
- Jayanta Badalchandra Das - Director
- Kamlesh Badal Das - Director
- Satish Prabhakar Nachane - Director
- Ramesh Eknath Jadhav - Director
- Sabu Daniel - Director
- Kashinath Badal Das - Director
- Mehul Satish Nachane - Director
- Bimlesh Badalchandra Das - Director
The primary industry of Danopharm Private Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Danopharm Private Limited can be reached at the registered office: Unit No 117 Ravi Kiran 1St Floor Near Monginis Off New Link Road AndheriWest, Mumbai, Maharashtra, India – 400053, or through the website danopharm.com.
The authorised capital is ₹2 Cr, and the paid-up capital is ₹2 Cr.